Megmastop 0.03mg/0.15mg Tablet
By Megmastop
Rx
21 Tablet in a Strip

Composition
Ethinyl Estradiol(0.03mg) + Desogestrel(0.15mg)

Manufacturer - Ridhima Biocare
SCO-30, Cabin No 1, First Floor, Preet Complex, Sector 12-A, Rally, Panchkula,134109, Haryana, India

Expires on or after
July, 2025

liver
When using Megmastop 0.03mg/0.15mg Tablet, caution is advised for patients with liver disease. It may be necessary to adjust the dose of Megmastop 0.03mg/0.15mg Tablet in such cases. It is important to consult your doctor before taking this medication. Patients with severe liver disease or active liver disease are not recommended to use Megmastop 0.03mg/0.15mg Tablet.

kidney
Limited information is available on using Megmastop 0.03mg/0.15mg Tablet in patients with kidney disease. Consult your doctor for advice before using.

alcohol
When taking Megmastop 0.03mg/0.15mg Tablet, it is important to be cautious when drinking alcohol. Consult your doctor for guidance on alcohol consumption while on this medication.

driving
It's generally safe to drive while taking Megmastop 0.03mg/0.15mg Tablet as it does not typically impact driving abilities.

pregnancy
During pregnancy, it is not safe to use Megmastop 0.03mg/0.15mg Tablet. Studies have found harmful effects on developing babies. Consult your doctor for guidance.

breastfeeding
Megmastop 0.03mg/0.15mg Tablet should not be used while breastfeeding due to potential toxicity to the baby. It is recommended to consider nonhormonal or progestin-only contraceptives, particularly in the first 4 weeks postpartum.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | GYNAECOLOGICAL |
Action Class | - |
₹175
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 18-Nov-2024